The Effects of Particle Size and Molecular Targeting on the Intratumoral and Subcellular Distribution of Polymeric Nanoparticles
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The current study describes the impact of particle size and/or molecular targeting (epidermal growth factor, EGF) on the in vivo transport of block copolymer micelles (BCMs) in athymic mice bearing human breast cancer xenografts that express differential levels of EGF receptors (EGFR). BCMs with diameters of 25 nm (BCM-25) and 60 nm (BCM-60) were labeled with indium-111 ((111)In) or a fluorescent probe to provide a quantitative and qualitative means of evaluating their whole body, intratumoral, and subcellular distributions. BCM-25 was found to clear rapidly from the plasma compared to BCM-60, leading to an almost 2-fold decrease in their total tumor accumulation. However, the tumoral clearance of BCM-25 was delayed through EGF functionalization, enabling the targeted BCM-25 (T-BCM-25) to achieve a comparable level of total tumor deposition as the nontargeted BCM-60 (NT-BCM-60). Confocal fluorescence microscopy combined with MATLAB analyses revealed that NT-BCM-25 diffuses further away from the blood vessels (D(mean) = 42 +/- 9 microm) following extravasation, compared to NT-BCM-60 which mainly remains in the perivascular regions (D(mean) = 23 +/- 4 microm). The introduction of molecular targeting imposes the "binding site barrier" effect, which retards the tumor penetration of T-BCM-25 (D(mean) = 29 +/- 7 microm, p < 0.05). The intrinsic nuclear translocation property of EGF/EGFR leads to a significant increase in the nuclear uptake of T-BCM-25 in vitro and in vivo via active transport. Overall, these results highlight the need to consider multiple design parameters in the development of nanosystems for delivery of anticancer agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In some previous studies, it was shown that sizes from 50 nm–100 nm are effective in preclinical models, suggesting ideal particle size distribution is necessary for efficacy of polymeric micelles [253, 254].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [254]
Citations
Cites
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Nano-engineering block copolymer aggregates for drug delivery
Allen, C., Maysinger, D., & Eisenberg, A. (1999) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00058-2 · Cited by 1,358
Self-citationMicellar Nanocontainers Distribute to Defined Cytoplasmic Organelles
Savić, R., Luo, L., Eisenberg, A., & Maysinger, D. (2003) · Science · doi:10.1126/science.1078192 · Cited by 1,113
Sonavane, G., Tomoda, K., & Makino, K. (2008) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2008.07.004 · Cited by 1,100
Nishiyama, N., & Kataoka, K. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.006 · Cited by 1,052
Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers
Dreher, M. R., Liu, W., Michelich, C. R., Dewhirst, M. W., Yuan, F., & Chilkoti, A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj070 · Cited by 920
Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.
Yokota, T., Milenic, D. E., Whitlow, M. D., & Schlom, J. (1992) · PubMed · Cited by 819
Nuclear Pore Complex Is Able to Transport Macromolecules with Diameters of ∼39 nm
Panté, N., & Kann, M. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-06-0308 · Cited by 776
Bae, Y., Nishiyama, N., Fukushima, S., Koyama, H., Yasuhiro, M., & Kataoka, K. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0498166 · Cited by 742
Shuai, X., Ai, H., Nasongkla, N., Kim, S., & Gao, J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.003 · Cited by 695
Bae, Y., & Kataoka, K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.016 · Cited by 669
Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance
Thurber, G. M., Schmidt, M. M., & Wittrup, K. D. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.04.012 · Cited by 624
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Okusaka, T., Ueno, H., Ikeda, M., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602204 · Cited by 623
Pluen, A., Boucher, Y., Ramanujan, S., McKee, T. D., Gohongi, T., di Tomaso, E., Brown, E. B., Izumi, Y., Campbell, R. B., Berk, D. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081626898 · Cited by 603
Hamaguchi, T., Matsumura, Y., Suzuki, M., Shimizu, K., Goda, R., Nakamura, I., Nakatomi, I., Yokoyama, M., Kataoka, K., & Kakizoe, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602479 · Cited by 565
The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors
Primeau, A. J., Rendon, A., Hedley, D., Lilge, L., & Tannock, I. F. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1664 · Cited by 499
Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., & Maeda, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00563.x · Cited by 470
Juweid, M. E., Neumann, R. D., Paik, C. H., Pérez-Bacete, M., Sato, J., van Osdol, W. W., & Weinstein, J. N. (1992) · PubMed · Cited by 406
Self-assembly and properties of diblock copolymers by coarse-grain molecular dynamics
Srinivas, G., Discher, D. E., & Klein, M. L. (2004) · Nature Materials · doi:10.1038/nmat1185 · Cited by 376
Increased nanoparticle penetration in collagenase-treated multicellular spheroids.
Goodman, T. T., Olive, P. L., & Pun, S. H. (2007) · PubMed Central · Cited by 362
Mikhail, A. S., & Allen, C. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.010 · Cited by 328
Self-citationPrabaharan, M., Grailer, J. J., Pilla, S., Steeber, D. A., & Gong, S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.011 · Cited by 317
Factors determining antibody distribution in tumors
THURBER, G., SCHMIDT, M., & WITTRUP, K. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.11.004 · Cited by 223
Costantini, D. L., Chan, C., Cai, Z., Vallis, K. A., & Reilly, R. M. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037937 · Cited by 190
Self-citationJackson, D. E. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00224-2 · Cited by 175
Thorne, R. G., Hrabětová, S., & Nicholson, C. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00352.2004 · Cited by 168
Fate of micelles and quantum dots in cells
Maysinger, D., Lovrić, J., Eisenberg, A., & Savić, R. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.08.011 · Cited by 160
Spatio‐temporal modeling of nanoparticle delivery to multicellular tumor spheroids
Goodman, T. T., Chen, J., Matveev, K., & Pun, S. H. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21910 · Cited by 158
In Vivo Distribution of Polymeric Nanoparticles at the Whole-Body, Tumor, and Cellular Levels
Lee, H., Hoang, B., Fonge, H., Reilly, R. M., & Allen, C. J. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0068-z · Cited by 138
Self-citationNanomedicine : A Great First Year And, with Your Help, A Bright Future Ahead
Martin, C. R. (2007) · Nanomedicine · doi:10.2217/17435889.2.3.265 · Cited by 130
Zeng, F., Lee, H., & Allen, C. J. (2006) · Bioconjugate Chemistry · doi:10.1021/bc050350g · Cited by 110
Self-citationFactors affecting toxicity and efficacy of polymeric nanomedicines
Igarashi, E. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.02.007 · Cited by 100
Lee, H., Zeng, F., Dunne, M., & Allen, C. (2005) · Biomacromolecules · doi:10.1021/bm050451h · Cited by 95
Self-citationPharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles
Yang, Z., Leon, J. W., Martin, M., Harder, J., Zhang, R., Liang, D., Lü, W., Tian, M., Gelovani, J. G., Qiao, A., et al. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/16/165101 · Cited by 94
Hoang, B., Lee, H., Reilly, R. M., & Allen, C. (2009) · Molecular Pharmaceutics · doi:10.1021/mp8002418 · Cited by 83
Self-citationCostantini, D. L., Hu, M., & Reilly, R. M. (2008) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2007.0430 · Cited by 73
Self-citationLee, H., Hu, M., Reilly, R. M., & Allen, C. J. (2007) · Molecular Pharmaceutics · doi:10.1021/mp0700559 · Cited by 65
Self-citationSoluble, crosslinked N-(2-hydroxypropyl)methacrylamide copolymers as potential drug carriers
Cartlidge, S. A., Duncan, R., Lloyd, J. B., Kopečkova—Rejmanová, P., & Kopec̆ek, J. (1987) · Journal of Controlled Release · doi:10.1016/0168-3659(87)90018-6 · Cited by 49
Thermoresponsive, Hydrolytically Degradable Polymer Micelles Intended for Radionuclide Delivery
Hrubý, M., Koňák, Č., Kučka, J., Vetrík, M., Filippov, S. K., Větvička, D., Macková, H., Karlsson, G., Edwards, K., Říhová, B., et al. (2009) · Macromolecular Bioscience · doi:10.1002/mabi.200900083 · Cited by 49
Hu, M., Scollard, D. A., Chan, C., Chen, P. L., Vallis, K. A., & Reilly, R. M. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.06.010 · Cited by 43
Self-citationHolt, S. J., Alexander, P. M., Inman, C. B. E., & Davies, D. E. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90444-8 · Cited by 41
Fonge, H., Lee, H., Reilly, R. M., & Allen, C. J. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900201v · Cited by 34
Self-citationZeng, F., & Allen, C. J. (2006) · Macromolecules · doi:10.1021/ma0607665 · Cited by 29
Self-citation
Research works printed but not linked: 6
- Yokota T., 1992, Cancer Res., 52, 3402
- Amiji, M. M.Nanotechnology for cancer therapy;CRC/Taylor & Francis:Boca Raton, 2007; p817,[8] of plates.
- Yuan F., 1995, Cancer Res., 55, 3752
- Juweid M., 1992, Cancer Res., 52, 5144
- Thurber G. M., 2008, Trends Pharmacol. Sci., 29, 57
- Costantini D. L., 2008, Cancer Biother. Radiopharm., 23, 3
Cited by
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Albanese, A., Tang, P. S., & Chan, W. C. W. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150124 · Cited by 3,633
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
The Effect of Nanoparticle Size on In Vivo Pharmacokinetics and Cellular Interaction
Hoshyar, N., Gray, S., Han, H., & Bao, G. (2016) · Nanomedicine · doi:10.2217/nnm.16.5 · Cited by 1,990
Targeted drug delivery to tumors: Myths, reality and possibility
Bae, Y. H., & Park, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.001 · Cited by 1,935
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Metadata
- Authors
- Lee, H., Fonge, H., Hoang, B., Reilly, R. M., & Allen, C.
- Affiliations
- University Health Network (CA)
- Corresponding author
- Allen, Christine
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-05-26
- Volume
- 7
- Issue
- 4
- Pages
- 1195-1208
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W1985006200
- Cited by
- 349
- References
- 46
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 18 · 2023: 15 · 2022: 10 · 2021: 24 · 2020: 35 · 2019: 30 · 2018: 23 · 2017: 35 · 2016: 26 · 2015: 24 · 2014: 28 · 2013: 26 · 2012: 24
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- polymeric nanoparticles, block copolymer micelles, particle size, molecular targeting, epidermal growth factor, EGFR, intratumoral distribution, subcellular localization, tumor penetration, nuclear translocation, tumor xenografts, breast cancer, indium-111 labeling, nanoparticle clearance
- MeSH terms
- Animals, Breast Neoplasms, Drug Carriers, Epidermal Growth Factor, Female, Humans, Mice, Nude, Particle Size, Polymers, Microscopy, Confocal, Xenograft Model Antitumor Assays, Cell Line, Tumor, Mice, Nanoparticles, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.